About CARDIS Labs
CARDIS Labs was a Healthcare company based in Jaipur (India) founded in 2017 by Atul Kumar Shanker and Vaibhav Shanker. It delivers mass spectroscopy-based software for microbial identification. It operates on a B2B model. Its Indian entity Cardis Labs Private Limited reported revenue of ₹7.3 Lakh. The company is recorded as dissolved. Its focus areas include Biotechnology, Microbial Identification and Software Solutions. Similar companies include Olympus, Inflammatix, MeMed, GenMark Diagnostics and Sunbird Bio and 5 more; 8 of its 10 listed similar companies have raised funding.
Company details
CARDIS Labs operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, microbial identification, and providing software for education. Delivers mass spectroscopy-based software for microbial identification. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Jaipur, India
- Founders Atul Kumar Shanker, Vaibhav Shanker
- SectorsHealthcare
- Website cardislabs.in
- Legal Name Cardis Labs Private Limited
- Date of Incorporation 11 Jul, 2017
- Jurisdiction Jaipur, Rajasthan, India
- Annual Revenue₹7.3 Lakh
FY 2025 · -89% YoY
- Net Loss-₹11.3 Lakh
FY 2025 · -155% margin
- EBITDA-₹3 Lakh
FY 2025 · -41% margin
Associated legal entities of CARDIS Labs
CARDIS Labs operates through Cardis Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cardis Labs Private Limited CIN U73100RJ2017PTC058536 | Active | 11 Jul 2017 | Jaipur, Rajasthan | ₹0.1 Cr | – | 3 | View details |
Board of directors of Cardis Labs Private Limited (CARDIS Labs)
Cardis Labs Private Limited is the primary company behind CARDIS Labs. The board of Cardis Labs Private Limited currently have 3 directors; the longest-serving is Atul Kumar Shankar, appointed in 2017.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Atul Kumar Shankar DIN 02238011 | Director | 11 Jul 2017 | 9 yrs 3 mo | Cardis Labs Private Limited |
| Vaibhav Shanker DIN 06894265 | Director | 11 Jul 2017 | 9 yrs 3 mo | Cardis Labs Private Limited |
| Varnit Shanker DIN 08083721 | Director | 19 Mar 2018 | 8 yrs 7 mo | Cardis Labs Private Limited |
People of CARDIS Labs
2 people are tracked at CARDIS Labs (2 in leadership).
| Name | Role | Group |
|---|---|---|
Atul Kumar Shanker | Co-Founder, Director | Leadership |
| Co-Founder, COO | Leadership |
Complete people profiles for CARDIS Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of CARDIS Labs
Figures of Cardis Labs Private Limited, the primary company behind CARDIS Labs, for FY 2025. Revenue was ₹7.3 Lakh (-89% year on year). Net loss was -₹11.3 Lakh (-155% margin). EBITDA was -₹3 Lakh (-41% margin). Revenue has grown at a compounded annual rate of -68% over three years and -31% over five years.
- ₹7.3 LakhRevenue · FY 2025 · -89% YoY
- -₹11.3 LakhNet loss · -155% margin
- -₹3 LakhEBITDA · -41% margin
- ₹1 LakhPaid-up capital
- -68%Revenue CAGR, 3 years
- -31%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cardis Labs Private Limited are on its company page.
Detailed financial statements for CARDIS Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to CARDIS Labs
CARDIS Labs has 10 listed similar companies in our database, 8 of them funded. They include Olympus, Inflammatix, MeMed, GenMark Diagnostics and Sunbird Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| olympus-global.com | 1919 | Tokyo, Japan | – | 35,933 | Manufacturer of imaging and surgical products | |
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| me-med.com | 2009 | Tirat Carmel, Israel | $163M | – | Provider of machine learning based diagnostic solutions for infectious diseases | |
| genmarkdx.com | 1993 | San Diego, United States | $8.56M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. | |
| sunbirdbio.com | 2020 | Singapore | $14M | – | Diagnostic technologies for infectious, cancer, and neurological diseases are developed. | |
| t2biosystems.com | 2006 | Lexington, United States | $454.3M | 166 | Miniaturized MRI platforms for clinical diagnostics are developed. | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| molbiodiagnostics.com | 2000 | Salcete, India | $123.98M | 714 | Point-of-care molecular platforms for infectious disease detection are developed. | |
| parksystems.com | 1997 | Suwon-si, South Korea | – | – | Scanning probe microscopes are manufactured for nanoimaging applications. | |
| visbymedical.com | 2010 | San Jose, United States | $386.33M | 251 | Portable PCR diagnostics for infectious diseases are developed. |
Detailed similar companies of CARDIS Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Microbiome Therapeutics
10 companies that operate in the same segment as CARDIS Labs (Microbiome Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Biosolutions and enzymes are developed for biotechnology applications across industries. | 2000 | Bags Sword, Denmark | – | – | – | |
Pendulum is focused on developing advanced probiotic solutions. | 2012 | San Francisco, California, United States | USD 109.5 M | – | 55 | |
Gut microbiome insights, analytics, tests, and therapeutics are provided. | 2019 | Singapore, Singapore | USD 10.5 M | USD 1.37 M | – | |
Microbiome-based therapeutics for skin conditions like eczema are developed. | 2014 | Farmington, United States | USD 37.4 M | – | 12 | |
Engineered microbes are developed as programmable therapeutics for metabolic disorders. | 2013 | Cambridge, Massachusetts, United States | USD 34.4 M | USD 8 K | 1 | |
Therapeutics for infectious and autoimmune diseases are developed. | 2010 | Cambridge, Massachusetts, United States | USD 470.49 M | – | 71 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Microbiome-based therapeutics for gut diseases are developed. | 2017 | Edinburgh, Scotland, United Kingdom | USD 72.96 M | – | 65 | |
The gut-brain axis is explored for therapeutic and nutritional innovations. | 2014 | New York, New York, United States | USD 479 M | – | 84 | |
Microbiome therapeutics are developed to address diverse diseases. | 2010 | Cambridge, Massachusetts, United States | USD 257.13 M | USD 789 K | 103 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CARDIS Labs
CARDIS Labs was founded in 2017.
CARDIS Labs is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
The primary company behind CARDIS Labs, Cardis Labs Private Limited, reported revenue of ₹7.3 Lakh for FY 2025, down 89% year on year.
CARDIS Labs operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, microbial identification, and providing software for education. Delivers mass spectroscopy-based software for microbial identification. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
CARDIS Labs's top competitors include Visby Medical, Inflammatix and MeMed.
CARDIS Labs operates through Cardis Labs Private Limited.
The legal entities of CARDIS Labs currently have 3 directors, including Atul Kumar Shankar, Varnit Shanker, Vaibhav Shanker.